Uterus transplantation: where do we stand today and where should we go?

Author： Brännström Mats   Wranning Caiza Almén  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.4, 2007-04, pp. : 427-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegasparaginase: where do we stand?

By Zeidan Amer   Wang Eunice S   Wetzler Meir  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 111-119

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy and immunoprevention of cancer: where do we stand?

By Cavallo Federica   Curcio Claudia   Forni Guido  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 717-726

Informa Healthcare

Access to resources Recommend Favorite

Perspectives on MAO-B in aging and neurological disease: Where do we go from here?

By Kumar M.   Andersen Julie  

Molecular Neurobiology, Vol. 30, Iss. 1, 2004-08 ,pp. : 77-89

Humana Press, Inc

Access to resources Recommend Favorite

Structure and function of xanthine oxidoreductase: where are we now?

By Harrison R.  

Free Radical Biology and Medicine, Vol. 33, Iss. 6, 2002-09 ,pp. : 774-797

Elsevier

Access to resources Recommend Favorite

Proteomic techniques for finding biomarkers for prenatal screening for Down syndrome: where are we?

By Wang Qiu-Wei   Yu Bin  

Expert Review of Proteomics, Vol. 9, Iss. 6, 2012-12 ,pp. : 583-585

Informa Healthcare

Access to resources Recommend Favorite